Valsartan Recall Cancer Lawsuits
NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
When it comes to ‘lawsuits’ stemming from design and manufacturing defects related to the Stryker Rejuvenate and ABG II hips, the majority of them are consolidated into a Multi District Litigation format (MDL) in the United States District Court of Minnesota. Per MDL rules, the cases are filed and tried individually but are consolidated for purposes of discovery and case management as there are similarities between the underlying cases. The Stryker MDL (No.: 13-2441) was established last year and the cases are set before Magistrate Judge Franklin L. Noel and District Judge Donovan W. Frank.
In July 2012, Stryker recalled its hip implant models Rejuvenate and ABG II. They have now advised all recipients of these models to consult a medical professional and be checked regularly, irrespective of whether they have experienced any problems with the implant or not. This announcement comes after hundreds of users of the implants complained that they were suffering from complications such as severe and consistent pain, swelling, and failure of the implants. The FDA, after being bombarded with such allegations, instructed the Stryker Corporation to halt production and distribution of their metal on metal hip implants.